N-Benzyloxycarbonyl-L-isoleucine dicyclohexylamine salt, 97%, 500g

2-((tert-Butoxycarbonyl)amino)-3-(5-methyl-1H-indol-3-yl)propanoic acid, 95%, 250mg

3,5-Difluoro-2-methoxybenzoyl chloride, 5g

2-Cyano-N-(4-fluoro-phenyl)-acetamide, 97.0%, 10g

2-(4-((Benzyloxy)carbonyl)-1,4-diazepan-1-yl)acetic acid hydrochloride, 100mg

Ethyl 5-methyloxazole-2-carboxylate, 95.0%, 1g

2-(3-Methoxythiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

(2-methyl-2-propen-1-yl)hydrazine, 95.0%, 250mg

(4-Fluoro-benzyl)-piperidin-3-yl-amine hydrochloride, 1g

2-Hydroxy-5-(hydroxymethyl)benzaldehyde, 98.0%, 10g

2-Methyl[1,8]-Naphthyridine, 97.0%, 10g

1H-Pyrrolo[3,2-b]pyridine-6-carbonitrile, 95.0%, 250mg